Acute Influence of Resveratrol Supplementation and Beet Extract in Recovery After Exercise in Coronary Paths
NCT ID: NCT06095635
Last Updated: 2023-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2022-03-10
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Beetroot Extract and Its Influence on Cardiovascular and Autonomic Recovery From the Effort in Healthy Males
NCT05294198
Nitrate, Exercise and Vascular Function in Midlife Women
NCT06527248
Effects of Beetroot Juice in Postmenopausal and Hypertensive
NCT03620227
NO3-rich Beet Juice and Exercise on Postmenopausal Women Cardiovascular Health
NCT05384340
Determination of the Independent Effects of Beetroot Juice Components, Dietary Nitrate and Antioxidants, on Exercise Tolerance and Health Benefits in Individuals With Obesity
NCT03545009
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo Protocol
exercise and placebo capsules 500 mg (starch)
Placebo Protocol
ingestion of 500 mg of starch following 30 minutes of exercise (treadmill)
Protocol Beet
exercise and beet extract 500 mg
Protocol Beet
ingestion of 500 mg of beet extect following 30 minutes of exercise (treadmill)
Protocol Resveratrol
exercise and resveratrol capsules 500 mg
Protocol Resveratrol
ingestion of 500 mg of resveratrol following 30 minutes of exercise (treadmill)
Protocol Beet and Resveratrol
exercise and beet extract 500mg and resveratrol capsules 500 mg
Protocol Beet and Resveratrol
ingestion 500 mg of beet extect and 500 mg of resveratrol following 30 minutes of exercise (treadmill)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo Protocol
ingestion of 500 mg of starch following 30 minutes of exercise (treadmill)
Protocol Beet
ingestion of 500 mg of beet extect following 30 minutes of exercise (treadmill)
Protocol Resveratrol
ingestion of 500 mg of resveratrol following 30 minutes of exercise (treadmill)
Protocol Beet and Resveratrol
ingestion 500 mg of beet extect and 500 mg of resveratrol following 30 minutes of exercise (treadmill)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosed with ischemic coronary artery disease and with preserved left ventricular function (above 50%), confirmed by a previous echocardiogram
Exclusion Criteria
* smokers
* alcohol drinkers
* those who did not attend a cardiovascular rehabilitation program for at least 3 months prior to data collection
* individuals who have known infections, metabolic and respiratory diseases that could interfere in cardiac autonomic control, unstable angina, uncontrolled hypertension, significant valvular disease, uncontrolled metabolic disease (e.g., uncontrolled diabetes and thyroid disease)
40 Years
79 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Estadual Paulista Júlio de Mesquita Filho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luana Almeida Gonzaga
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Estadual Paulista
Presidente Prudente, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UEPJMG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.